NCT03020121View on ClinicalTrials.gov

Validation of BD Onclarity™ HPV Assay With PreservCyt® -ASCUS Samples

NATerminatedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions
Uterine Cervical Neoplasm
Interventions
PROCEDURE

Colposcopy/biopsy

Colposcopy/biopsy will be performed on all subjects

Trial Locations (12)

10533

Research Pathology Associates, LLC, Irvington

22901

Research Pathology Associates, Charlotte

33409

Comprehensive Clinical Trials, LLC, West Palm Beach

46202

Indiana University, Indianapolis

Sidney & Lois Eskenazi Hospital, Indianapolis

68164

Transgenomics, Omaha

78233

Center for Disease Detection, San Antonio

80207

Planned Parenthood of the Rocky Mountains, Denver

80222

American Pathology Partners Inc., Denver

87102

Southwest Womens Health, Albuquerque

Tricore Reference Lab, Albuquerque

H2V 3J11

BioVision, Outremont

Sponsors
All Listed Sponsors
lead

Becton, Dickinson and Company

INDUSTRY